Michihiro Ogasawara Selected Research

Michihiro Ogasawara Research Topics

9	Rheumatoid Arthritis 02/2022 - 10/2006
2	Arthritis (Polyarthritis) 09/2019 - 06/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2018 - 08/2016
2	Infections 10/2016 - 06/2009
1	Giant Cell Arteritis (Horton Disease) 09/2019
1	Pathologic Constriction (Stenosis) 09/2019
1	Headache (Headaches) 09/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2018
1	Lupus Nephritis 01/2017
1	Drug Hypersensitivity (Drug Allergy) 10/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2012
1	Lymphoma (Lymphomas) 06/2012
1	Psoas Abscess 06/2009
1	Low Back Pain (Lumbago) 06/2009
1	Abscess 06/2009

3	Antirheumatic Agents (DMARD)IBA 03/2018 - 02/2012
2	MicroRNAs (MicroRNA)IBA 06/2018 - 08/2016
2	Methotrexate (Mexate)FDA LinkGeneric 03/2018 - 10/2006
2	AntibodiesIBA 03/2018 - 11/2011
1	Abatacept (Orencia)FDA Link 02/2022
1	C-Reactive ProteinIBA 09/2019
1	SteroidsIBA 09/2019
1	GlucocorticoidsIBA 09/2019
1	Prednisolone (Predate)FDA LinkGeneric 09/2019
1	Rheumatoid FactorIBA 03/2018
1	RNA (Ribonucleic Acid)IBA 03/2018
1	cyclic citrullinated peptideIBA 03/2018
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 03/2018
1	Ligases (Synthetase)IBA 03/2018
1	Biological ProductsIBA 03/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Pharmaceutical PreparationsIBA 10/2016
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Adalimumab (Humira)FDA Link 06/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011
1	Anti-Idiotypic AntibodiesIBA 11/2011
1	Tumor Necrosis Factor InhibitorsIBA 11/2011
1	Methicillin (Metin)FDA Link 06/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2009
1	Therapeutic UsesIBA 10/2006

4	Therapeutics 10/2016 - 02/2012
1	Biological Therapy 07/2020
1	Plasmapheresis 08/2016
1	Blood Component Removal (Apheresis) 08/2016
1	Acupuncture Therapy 06/2009